Hellvard, Annelie
Zeitlmann, Lutz
Heiser, Ulrich
Kehlen, Astrid
Niestroj, André
Demuth, Hans-Ulrich
Koziel, Joanna
Delaleu, Nicolas
Jan Potempa,
Mydel, Piotr
Article History
Received: 19 April 2016
Accepted: 20 July 2016
First Online: 11 August 2016
Competing interests
: U.H., A.K. and A.N. are former or present employees of Probiodrug. L.Z. is former employee of Ingenium Pharmaceuticals. H.U.D. is chief science officer of Probiodrug and managing director of Ingenium Pharmaceuticals, a daughter company of Probiodrug and holds stock in the Probiodrug group. All other authors report no potential conflicts.